Monitoring of Facilities. 5.5.1 Canada shall monitor the various phases of the Projects or Elements of the Project in compliance with the applicable laws and as part of its agreement to communicate fully with the affected Parties shall provide to the Parties full and timely information.
5.5.2 Without limiting the generality of the foregoing, Canada will, in consultation with the affected Municipality, or its CAC, establish and maintain a monitoring plan for each Facility which plan will be consistent with the conditions of licence for the Facility. Canada shall regularly provide each Party a copy of the monitoring reports for the Facility in their respective Municipality forthwith after they have been filed with the CNSC.
Monitoring of Facilities. Customer shall have the right to have a representative present at each Facility to observe the performance of the Manufacturing Process by Supplier during normal business hours with at least [* * *] advance notice. Supplier shall have the right to reasonably restrict such observation access to prevent undue interference with Supplier’s business operations or compromise Supplier’s confidentiality obligations to Third Parties; provided, however, Customer’s observation access shall be absolute with regard to the Manufacturing Process for the Product. As such it is Supplier’s obligation to segregate Third Party documents and materials from Customer’s documents and materials and Customer will not be restricted from observing any part of Customer’s Manufacturing Process and related documentation.
Monitoring of Facilities. Vendor must employ monitoring for all areas where Confidential Information is used in a manner commensurate with the sensitivity of Confidential Information. Vendor’s security controls must include, among others, closed circuit television cameras (CCTV), to ensure the above. Vendor must regularly review reports of user entry into Vendor’s facilities housing Confidential Information.
Monitoring of Facilities. King shall have the right at all times throughout the Term to have two of its representatives present in that portion of Core’s Manufacturing facilities that is being used to Manufacture Authorized Generic Product or store Materials to observe the procedures and processes used to Manufacture Authorized Generic Product and who shall have full access to all of Core’s Manufacturing facilities and records that relate to Authorized Generic Product and any Materials.
Monitoring of Facilities. PONIARD shall have the right to have representatives of its (or its designee’s) quality assurance or manufacturing personnel present in Heraeus’s facilities to observe the manufacturing activities. Heraeus shall use its best efforts to prevent Third Parties from observing Picoplatin API Batch Processing at the Facility.
